Streetbeat News

Analyst Ratings

PAYO

Needham analyst Mayank Tandon maintains a Buy rating on Payoneer Global (NASDAQ:PAYO) and raises the price target from $9 to $10.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 10:07 am

ACCD

Needham analyst Ryan MacDonald has reiterated a Buy rating on Accolade (NASDAQ:ACCD) and maintained a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 10:04 am

CURB

Keybanc analyst Todd Thomas has initiated coverage on Curbline Properties (NYSE:CURB) with a Sector Weight rating.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 10:02 am

SITC

Keybanc analyst Todd Thomas has downgraded SITE Centers (NYSE:SITC) from Overweight to Sector Weight, indicating a neutral stance on the stock.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 9:57 am

SHW

Keybanc analyst Aleksey Yefremov has downgraded Sherwin-Williams (NYSE:SHW) from Overweight to Sector Weight, indicating a more cautious outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 9:55 am

CE

Keybanc analyst Aleksey Yefremov has downgraded Celanese (NYSE:CE) from Overweight to Sector Weight, indicating a more cautious outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 9:52 am

CPNG

Bernstein analyst Bokyung Suh has upgraded Coupang (NYSE:CPNG) from Underperform to Outperform, setting a new price target of $30.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 9:48 am

HSY

Bernstein analyst Alexia Howard has downgraded Hershey (NYSE:HSY) from Outperform to Market Perform and reduced the price target from $230 to $205.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 9:39 am

CLMT

HC Wainwright & Co. analyst Amit Dayal has reiterated a Buy rating for Calumet (NASDAQ:CLMT) and maintained a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 9:35 am

RVMD

Needham analyst Ami Fadia has reiterated a Buy rating on Revolution Medicines (NASDAQ:RVMD) and maintained a price target of $61.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 9:30 am